CTNM Competitors & Alternatives
Compare Contineum Therapeutics, Inc. Class A Common Stock with similar stocks in the same industry
Biotechnology
CTNM
Main Stock$11.93
Tradestie Score
52
Market Cap
$308.74M
Analyst Upside
+87.3%
Top Competitors
221 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
XOMA
XOMA Royalty Corporation Common Stock
|
$41.95
|
$474.20M | 26.7 | 59 | Compare |
|
ABSI
Absci Corporation Common Stock
|
$7.47
|
$468.01M | - | 58 | Compare |
|
GLUE
Monte Rosa Therapeutics, Inc. Common Stock
|
$20.58
|
$463.20M | - | 56 | Compare |
|
SLDB
Solid Biosciences Inc. Common Stock
|
$8.69
|
$457.09M | - | 62 | Compare |
|
MRVI
Maravai LifeSciences Holdings, Inc. Class A Common Stock
|
$5.34
|
$454.29M | - | 57 | Compare |
|
RAPT
RAPT Therapeutics, Inc. Common Stock
|
$58.02
|
$450.49M | - | 53 | Compare |
|
MLTX
MoonLake Immunotherapeutics Class A Ordinary Shares
|
$21.35
|
$448.32M | - | 65 | Compare |
|
ATXS
Astria Therapeutics, Inc. Common Stock
|
$12.58
|
$425.52M | - | 58 | Compare |
|
ALMS
Alumis Inc. Common Stock
|
$24.59
|
$422.50M | - | 56 | Compare |
|
DRUG
Bright Minds Biosciences Inc. Common Stock
|
$67.21
|
$410.79M | - | 50 | Compare |
More CTNM Analysis
Data updated: Jun 23, 2026 | Industry: Biotechnology (SIC 2834)
221 stocks in this industry